Sky Investment Group LLC Buys Shares of 1,786 Waters Corporation $WAT

Sky Investment Group LLC bought a new position in shares of Waters Corporation (NYSE:WAT) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 1,786 shares of the medical instruments supplier’s stock, valued at approximately $532,000.

Several other institutional investors also recently modified their holdings of WAT. Brighton Jones LLC boosted its stake in Waters by 112.9% during the 4th quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock worth $471,000 after acquiring an additional 673 shares during the last quarter. Integrated Wealth Concepts LLC grew its holdings in shares of Waters by 2.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock valued at $386,000 after buying an additional 30 shares during the period. Goldman Sachs Group Inc. grew its holdings in shares of Waters by 3.6% in the 1st quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock valued at $73,733,000 after buying an additional 6,976 shares during the period. Empowered Funds LLC raised its stake in Waters by 16.6% during the 1st quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock worth $415,000 after buying an additional 160 shares during the period. Finally, Sivia Capital Partners LLC acquired a new stake in Waters during the 2nd quarter worth $232,000. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have issued reports on WAT shares. Bank of America boosted their target price on Waters from $370.00 to $400.00 and gave the company a “neutral” rating in a research note on Tuesday, June 2nd. Piper Sandler assumed coverage on shares of Waters in a report on Thursday, June 11th. They issued a “neutral” rating and a $400.00 price target for the company. JPMorgan Chase & Co. increased their price objective on shares of Waters from $330.00 to $345.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. The Goldman Sachs Group raised shares of Waters to a “strong-buy” rating in a research report on Wednesday, April 1st. Finally, Robert W. Baird set a $387.00 target price on Waters in a report on Wednesday, May 6th. Three research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat, Waters currently has an average rating of “Moderate Buy” and an average price target of $394.56.

Waters Stock Performance

Shares of WAT stock opened at $356.26 on Monday. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $414.15. The company’s fifty day simple moving average is $342.66 and its 200-day simple moving average is $348.22. The firm has a market cap of $34.98 billion, a PE ratio of 45.27, a P/E/G ratio of 2.15 and a beta of 1.21. The company has a quick ratio of 1.13, a current ratio of 1.79 and a debt-to-equity ratio of 0.32.

Waters (NYSE:WAT) last posted its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $2.70 EPS for the quarter, topping analysts’ consensus estimates of $2.31 by $0.39. The company had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.20 billion. Waters had a net margin of 11.91% and a return on equity of 15.60%. The company’s quarterly revenue was up 91.4% on a year-over-year basis. During the same period in the prior year, the business posted $2.25 EPS. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. Equities research analysts expect that Waters Corporation will post 14.51 EPS for the current fiscal year.

Waters Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.